| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3269 |
| Trial ID | NCT05648019 |
| Disease | Childhood B-Cell Acute Lymphoblastic Leukemia | B-Cell Acute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia | Large B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol |
| Year | 2022 |
| Country | Singapore |
| Company sponsor | KK Women's and Children's Hospital |
| Other ID(s) | SHCELL18P1 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||